Introduction: Early palliative care (PC) integrated with oncology care improves quality of life (QOL), depression symptoms, illness understanding, and end-of-life (EOL) care for patients with advanced lung cancer. The aims of this trial are to compare the effect of delivering early integrated PC through telehealth versus in-person on patient and caregiver outcomes. We hypothesize that both modalities for delivering early PC would be equivalent for improving patient QOL, communication about EOL care preferences with their oncologist, and length of stay in hospice. Methods: For this comparative effectiveness trial, we will enroll and randomize 1250 adult patients with advanced nonsmall cell lung cancer (NSCLC), who are not being treated with curative intent, to receive either early integrated telehealth or in-person PC at 20 cancer centers throughout the United States. Patients may also invite a family caregiver to participate in the study. Patients and their caregivers in both study groups meet at least every four weeks with a PC clinician from within 12 weeks of patient diagnosis of advanced NSCLC until death. Participants complete measures of QOL, mood, and quality of communication with oncologists at baseline before randomization and at 12, 24, 36, and 48 weeks. Information on health care utilization, including length of stay in hospice, will be collected from patients' health records. To test equivalence in outcomes between study groups, we will compute analysis of covariance and mixed linear models, controlling for baseline scores and study site. Study Implementation and Stakeholder Engagement: To ensure that this comparative effectiveness trial and findings are as patient centered and meaningful as possible, we have incorporated a robust patient and stakeholder engagement plan. Our stakeholder partners include (1) patients/families, (2) PC clinicians, (3) telehealth experts and clinician users, (4) representatives from health care systems and medical insurance providers, and (5) health care policy makers and advocates. These stakeholders will inform and provide feedback about every phase of study implementation.
RCT Entities:
Introduction: Early palliative care (PC) integrated with oncology care improves quality of life (QOL), depression symptoms, illness understanding, and end-of-life (EOL) care for patients with advanced lung cancer. The aims of this trial are to compare the effect of delivering early integrated PC through telehealth versus in-person on patient and caregiver outcomes. We hypothesize that both modalities for delivering early PC would be equivalent for improving patient QOL, communication about EOL care preferences with their oncologist, and length of stay in hospice. Methods: For this comparative effectiveness trial, we will enroll and randomize 1250 adult patients with advanced nonsmall cell lung cancer (NSCLC), who are not being treated with curative intent, to receive either early integrated telehealth or in-person PC at 20 cancer centers throughout the United States. Patients may also invite a family caregiver to participate in the study. Patients and their caregivers in both study groups meet at least every four weeks with a PC clinician from within 12 weeks of patient diagnosis of advanced NSCLC until death. Participants complete measures of QOL, mood, and quality of communication with oncologists at baseline before randomization and at 12, 24, 36, and 48 weeks. Information on health care utilization, including length of stay in hospice, will be collected from patients' health records. To test equivalence in outcomes between study groups, we will compute analysis of covariance and mixed linear models, controlling for baseline scores and study site. Study Implementation and Stakeholder Engagement: To ensure that this comparative effectiveness trial and findings are as patient centered and meaningful as possible, we have incorporated a robust patient and stakeholder engagement plan. Our stakeholder partners include (1) patients/families, (2) PC clinicians, (3) telehealth experts and clinician users, (4) representatives from health care systems and medical insurance providers, and (5) health care policy makers and advocates. These stakeholders will inform and provide feedback about every phase of study implementation.
Entities:
Keywords:
early palliative care; lung cancer; telehealth
Authors: Jaclyn Yoong; Elyse R Park; Joseph A Greer; Vicki A Jackson; Emily R Gallagher; William F Pirl; Anthony L Back; Jennifer S Temel Journal: JAMA Intern Med Date: 2013-02-25 Impact factor: 21.873
Authors: Teresa L Hagan; Joel N Fishbein; Ryan D Nipp; Jamie M Jacobs; Lara Traeger; Kelly E Irwin; William F Pirl; Joseph A Greer; Elyse R Park; Vicki A Jackson; Jennifer S Temel Journal: J Pain Symptom Manage Date: 2016-10-08 Impact factor: 3.612
Authors: Camilla Zimmermann; Nadia Swami; Monika Krzyzanowska; Breffni Hannon; Natasha Leighl; Amit Oza; Malcolm Moore; Anne Rydall; Gary Rodin; Ian Tannock; Allan Donner; Christopher Lo Journal: Lancet Date: 2014-02-19 Impact factor: 79.321
Authors: Michael Hoerger; Joseph A Greer; Vicki A Jackson; Elyse R Park; William F Pirl; Areej El-Jawahri; Emily R Gallagher; Teresa Hagan; Juliet Jacobsen; Laura M Perry; Jennifer S Temel Journal: J Clin Oncol Date: 2018-02-23 Impact factor: 44.544
Authors: Roy E Strowd; Erin M Dunbar; Hui K Gan; Sylvia Kurz; Justin T Jordan; Jacob J Mandel; Nimish A Mohile; Kathryn S Nevel; Jennie W Taylor; Nicole J Ullrich; Mary R Welch; Andrea Wasilewski; Maciej M Mrugala Journal: Neurooncol Pract Date: 2022-01-17
Authors: Jennifer Barsky Reese; Areej El-Jawahri; Kristen Sorice; Christina Cruz; Sharon L Bober; Mary B Daly; Lauren A Zimmaro; Mary Catherine Beach; Elaine Wittenberg; Antonio C Wolff; Elizabeth Handorf; Stephen J Lepore Journal: Support Care Cancer Date: 2022-03-29 Impact factor: 3.359
Authors: Chithra R Perumalswami; Emily Chen; Carly Martin; Susan D Goold; Raymond De Vries; Jennifer J Griggs; Reshma Jagsi Journal: JCO Oncol Pract Date: 2021-07-29